Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong · Delayed Price · Currency is HKD 18.60
-0.03 (-0.16%)
Sep 10, 2025, 1:43 PM HKT
HKG:0874 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 75,550 | 74,779 | 75,275 | 70,550 | 68,758 | 61,450 | Upgrade |
Other Revenue | 234.67 | 214.3 | 240.53 | 237.96 | 256.1 | 223.35 | Upgrade |
| 75,785 | 74,993 | 75,515 | 70,788 | 69,014 | 61,674 | Upgrade | |
Revenue Growth (YoY) | -1.05% | -0.69% | 6.68% | 2.57% | 11.90% | -5.05% | Upgrade |
Cost of Revenue | 63,444 | 62,518 | 61,373 | 57,548 | 55,825 | 51,282 | Upgrade |
Gross Profit | 12,340 | 12,475 | 14,143 | 13,240 | 13,189 | 10,392 | Upgrade |
Selling, General & Admin | 7,908 | 8,003 | 8,484 | 8,062 | 7,955 | 6,396 | Upgrade |
Research & Development | 657.91 | 763.77 | 782.14 | 819.45 | 874.72 | 611.93 | Upgrade |
Other Operating Expenses | 315.44 | 175.29 | 6.38 | -182.76 | 294.43 | 257.59 | Upgrade |
Operating Expenses | 9,002 | 9,001 | 9,346 | 8,753 | 9,219 | 7,365 | Upgrade |
Operating Income | 3,339 | 3,474 | 4,796 | 4,487 | 3,970 | 3,026 | Upgrade |
Interest Expense | -408.81 | -418.15 | -446.19 | -434.41 | -417.83 | -363.34 | Upgrade |
Interest & Investment Income | 568.63 | 698.33 | 751.18 | 1,048 | 757.45 | 718.04 | Upgrade |
Currency Exchange Gain (Loss) | -2.43 | -3.15 | 3.32 | -11.12 | 8.67 | 2.1 | Upgrade |
Other Non Operating Income (Expenses) | -33.79 | -25.74 | -45.01 | -41.12 | -94.44 | -66.85 | Upgrade |
EBT Excluding Unusual Items | 3,462 | 3,725 | 5,060 | 5,048 | 4,224 | 3,316 | Upgrade |
Gain (Loss) on Sale of Investments | -372.88 | -361.01 | 38.64 | -3.59 | 196.88 | -16.14 | Upgrade |
Gain (Loss) on Sale of Assets | 14.46 | 11.12 | 12.03 | 0.69 | 0.69 | 2.95 | Upgrade |
Asset Writedown | -2.46 | -2.93 | 0.42 | -7.06 | -3.08 | -2.89 | Upgrade |
Legal Settlements | - | - | - | - | -24.82 | -12.02 | Upgrade |
Other Unusual Items | 367.13 | 235.17 | -0.36 | 4.76 | 329.44 | 450.86 | Upgrade |
Pretax Income | 3,469 | 3,608 | 5,110 | 5,043 | 4,723 | 3,739 | Upgrade |
Income Tax Expense | 559.97 | 606.85 | 851.17 | 789.87 | 754.09 | 647.45 | Upgrade |
Earnings From Continuing Operations | 2,909 | 3,001 | 4,259 | 4,253 | 3,969 | 3,092 | Upgrade |
Minority Interest in Earnings | -106.55 | -165.24 | -203.65 | -286.85 | -249.11 | -176.38 | Upgrade |
Net Income | 2,802 | 2,835 | 4,056 | 3,967 | 3,720 | 2,915 | Upgrade |
Net Income to Common | 2,802 | 2,835 | 4,056 | 3,967 | 3,720 | 2,915 | Upgrade |
Net Income Growth | -26.15% | -30.09% | 2.25% | 6.63% | 27.60% | -8.58% | Upgrade |
Shares Outstanding (Basic) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade |
Shares Outstanding (Diluted) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade |
Shares Change (YoY) | 0.00% | 0.02% | -0.02% | - | - | - | Upgrade |
EPS (Basic) | 1.72 | 1.74 | 2.50 | 2.44 | 2.29 | 1.79 | Upgrade |
EPS (Diluted) | 1.72 | 1.74 | 2.50 | 2.44 | 2.29 | 1.79 | Upgrade |
EPS Growth | -26.15% | -30.10% | 2.27% | 6.63% | 27.61% | -8.57% | Upgrade |
Free Cash Flow | 1,021 | 2,314 | 2,475 | 5,615 | 4,419 | -291.32 | Upgrade |
Free Cash Flow Per Share | 0.63 | 1.42 | 1.52 | 3.45 | 2.72 | -0.18 | Upgrade |
Dividend Per Share | 0.800 | 0.800 | 0.749 | 0.732 | 0.687 | 0.538 | Upgrade |
Dividend Growth | -30.37% | 6.81% | 2.32% | 6.55% | 27.69% | -8.66% | Upgrade |
Gross Margin | 16.28% | 16.63% | 18.73% | 18.70% | 19.11% | 16.85% | Upgrade |
Operating Margin | 4.41% | 4.63% | 6.35% | 6.34% | 5.75% | 4.91% | Upgrade |
Profit Margin | 3.70% | 3.78% | 5.37% | 5.60% | 5.39% | 4.73% | Upgrade |
Free Cash Flow Margin | 1.35% | 3.09% | 3.28% | 7.93% | 6.40% | -0.47% | Upgrade |
EBITDA | 3,915 | 4,068 | 5,462 | 5,002 | 4,390 | 3,415 | Upgrade |
EBITDA Margin | 5.17% | 5.42% | 7.23% | 7.07% | 6.36% | 5.54% | Upgrade |
D&A For EBITDA | 575.78 | 594.35 | 665.32 | 514.44 | 419.91 | 388.93 | Upgrade |
EBIT | 3,339 | 3,474 | 4,796 | 4,487 | 3,970 | 3,026 | Upgrade |
EBIT Margin | 4.41% | 4.63% | 6.35% | 6.34% | 5.75% | 4.91% | Upgrade |
Effective Tax Rate | 16.14% | 16.82% | 16.66% | 15.66% | 15.97% | 17.32% | Upgrade |
Revenue as Reported | - | - | - | - | - | 61,674 | Upgrade |
Advertising Expenses | - | 930.48 | 1,082 | 960.69 | 1,054 | 690.74 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.